Clinical Trial: Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901933) titled 'Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease' on Oct. 22.

Brief Summary: This is a Phase 1b, randomized, double-blinded, placebo-controlled study of CTX001 in participants with anemia and chronic kidney disease who are not on dialysis.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease Anemia

Intervention: DRUG: Placebo

Matching placebo administered orally once daily for 29 days.

DRUG: CTX001

CTX001 administered orally at the assigned cohort dose once daily for 29 days.

DRUG: Ferrous Sulfate

Ferrous sulfate administered orally once daily ...